Researchers are the first to create sensory interneurons from stem cells
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have, for the first time, coaxed human stem cells to become sensory interneurons — the cells that give us our sense of touch. The new protocol could be a step toward stem cell–based therapies to restore sensation in paralyzed people who have lost feeling in parts of their body.
The study, which was led by Samantha Butler, a UCLA associate professor of neurobiology and member of the Broad Stem Cell Research Center, was published today in the journal Stem Cell Reports.
Sensory interneurons, a class of neurons in the spinal cord, are responsible for relaying information from throughout the body to the central nervous system, which enables the sense of touch. The lack of a sense of touch greatly affects people who are paralyzed. For example, they often cannot feel the touch of another person, and the inability to feel pain leaves them susceptible to burns from inadvertent contact with a hot surface.
“The field has for a long time focused on making people walk again,” said Butler, the study’s senior author. “‘Making people feel again doesn’t have quite the same ring. But to walk, you need to be able to feel and to sense your body in space; the two processes really go hand in glove.”
In a separate study, published in September by the journal eLife, Butler and her colleagues discovered how signals from a family of proteins called bone morphogenetic proteins, or BMPs, influence the development of sensory interneurons in chicken embryos. The Stem Cell Reports research applies those findings to human stem cells in the lab.
When the researchers added a specific bone morphogenetic protein called BMP4, as well as another signaling molecule called retinoic acid, to human embryonic stem cells, they got a mixture of two types of sensory interneurons. DI1 sensory interneurons give people proprioception — a sense of where their body is in space — and dI3 sensory interneurons enable them to feel a sense of pressure.
The researchers found the identical mixture of sensory interneurons developed when they added the same signaling molecules to induced pluripotent stem cells, which are produced by reprogramming a patient’s own mature cells such as skin cells. This reprogramming method creates stem cells that can create any cell type while also maintaining the genetic code of the person they originated from. The ability to create sensory interneurons with a patient’s own reprogrammed cells holds significant potential for the creation of a cell-based treatment that restores the sense of touch without immune suppression.
Butler hopes to be able to create one type of interneuron at a time, which would make it easier to define the separate roles of each cell type and allow scientists to start the process of using these cells in clinical applications for people who are paralyzed. However, her research group has not yet identified how to make stem cells yield entirely dI1 or entirely dI3 cells — perhaps because another signaling pathway is involved, she said.
The researchers also have yet to determine the specific recipe of growth factors that would coax stem cells to create other types of sensory interneurons.
The group is currently implanting the new dI1 and dI3 sensory interneurons into the spinal cords of mice to understand whether the cells integrate into the nervous system and become fully functional. This is a critical step toward defining the clinical potential of the cells.
“This is a long path,” Butler said. “We haven’t solved how to restore touch but we’ve made a major first step by working out some of these protocols to create sensory interneurons.”
The Latest on: Stem cell–based therapies
- Stem cell breakthrough may give people with paralysis their sense of touch back on January 18, 2018 at 10:15 am
The protocol could be a crucial advance in stem cell-based therapies able to restore sensation in paralyzed individuals who have lost feeling in parts of their body. “Our work is exciting because we are the first to apply the right signals that tell stem ... […]
- The Trouble With Stem Cell Therapy on January 18, 2018 at 8:58 am
and have ordered at least one company to stop selling stem cell-based products. In November it declared that going forward, agency approval would be required for some stem cell therapies (the way it is for prescription drugs) and that clinics where ... […]
- 10 things about the new age regenerative stem cell therapy that you need to know on January 18, 2018 at 6:52 am
Regenerative medicine and cell-based therapies are taking the world by a storm in finding solutions for various diseases that plague mankind. Of specific interest is stem cell-based therapy which may be considered technically less demanding than other ... […]
- Newly FDA-Approved Platform Will Rapidly “Manufacture” Stem Cells to Repair Our Bodies on January 18, 2018 at 5:37 am
“With this new technology, we now can develop phase II trials enrolling larger numbers of patients to fully test the efficacy of cell-based therapies.” Mayo Clinic doctors plan to use the stem cell platform to advance therapies in areas like Alzheimer ... […]
- Stem-cell-based treatment aims to reverse Type 1 diabetes on January 16, 2018 at 5:31 am
About 10 British Columbians with Type 1 diabetes will be surgically implanted with packets containing lab-grown cells that are coaxed into behaving like true insulin-producing pancreatic cells in hopes of reversing their disease. The first patient to ... […]
- Cellect Announces Opening of a Second Clinical Trial Site and Approval from Safety Board (DSMB) for Dose Escalation on January 16, 2018 at 4:55 am
... breakthrough technology for the selection of stem cells from any given tissue that aims to improve a variety of stem cell-based therapies. The Company's technology is expected to provide research, hospitals and pharma companies with the tools to ... […]
- Asia-Pacific stem cell assay market is growing to reach USD 255.9 million by 2021 according to new research report on January 15, 2018 at 11:14 pm
It is due to the increasing adoption of stem cell based therapy and research in this region. Thermo Fisher Scientific Inc., GE Healthcare, Bio-Techne Corporation, Cellular Dynamics International Inc., Stem cell Technologies Inc., Merck KGaA, Promega ... […]
- Sensory Interneurons from Stem Cells Enable the Sense of Touch on January 14, 2018 at 12:00 am
Synopsis: New protocol could be a step toward stem cell-based therapies to restore sensation in paralyzed people who have lost feeling in parts of their body. Quote: "We haven't solved how to restore touch but we've made a major first step by working out ... […]
- UCLA scientists coax human stem cells to become sensory interneurons on January 11, 2018 at 12:00 am
The new protocol could be a step toward stem cell-based therapies to restore sensation in paralyzed people who have lost feeling in parts of their body. The study, which was led by Samantha Butler, a UCLA associate professor of neurobiology and member of ... […]
- Stem Cell Therapy Market 2017 Global Analysis,Research,Review,Applications and Forecast to 2023 on January 5, 2018 at 2:53 am
In addition, stem cell based therapies are also used to treat several chronic diseases such as blood disorders, cancer and others. Growing awareness about the potency of stem cells in disease management, development of advanced gene based analysis ... […]
via Google News and Bing News